Precision Biomarker Resources, Inc. Company Profile

09:56 EST 12th December 2018 | BioPortfolio

Precision accelerates its clients’ research and drug development by working closely with them on targeted biomarker discovery services, including microarray processing, experimental design consultation and data analysis. The team’s expertise, both scientific and technical, enhances every stage of the process, from discovery through preclinical, clinical and post-market studies. The laboratory is based in Evanston, Illinois, north of Chicago.


820 Davis Street, Suite 216
United States of America


Phone: 847-866-0406
Fax: 847-866-1877

News Articles [840 Associated News Articles listed on BioPortfolio]

No Silver-Bullet Biomarker for Precision RCC Care

Bryant FurlowJun 2, 2018No one molecular biomarker is likely to guide treatment of RCC in the foreseeable future. Multipredictor models might be a way forward, an expert concluded.

Patient-Experienced Toxicity Is a Biomarker Worth Considering

Maurie Markman, MD, says that the acceleration in regulatory agency approvals for novel antineoplastic agents and the focus of biomarker discovery proves that this is the era of precision me...

2018 Companion Diagnostics Market Report: Biomarker Platforms Enabling Precision Medicine –

DUBLIN–(BUSINESS WIRE)–The “Companion Diagnostics: Biomarker Platforms Enabling Precision Medicine” report has been added to’s offering. Both predi...

Syapse, NCCN partner to incorporate cancer biomarker data into precision medicine software

Integrating the NCCN’s Biomarker Compendium data into Syapse’s products is designed to aid finding targeted drugs and clinical trials while improving physician workflow.

New Thermo Fisher Center Offers Access to Precision Medicine Technologies, Expertise

BOSTON—Thermo Fisher Scientific has opened its U.S. Precision Medicine Science Center (PMSC) in neighboring Cambridge, MA, with a focus on advancing the company’s precision medicine efforts with c...

Precision Medicine and Public Health: Improving Health Now While Generating New Knowledge for the Future

June 2015 Precision Medicine and Public Health: Improving Health Now While Generating New Knowledge for the Future There is no doubt that the time is right for a large precision medicine coh...

New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker

A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications descr...

Syapse Precision Medicine Council Launches to Advance Precision Oncology Adoption

Syapse, a San Francisco, CA-based precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health ...

Drugs and Medications [61 Associated Drugs and Medications listed on BioPortfolio]

Loperamide hydrochloride [Precision Dose Inc.]


Childrens acetaminophen [Precision Dose Inc.]


Childrens cetirizine hydrochloride [Precision Dose Inc.]


Oxygen [Med Resources, Inc.]


Childrens ibuprofen [Precision Dose Inc.]


PubMed Articles [1263 Associated PubMed Articles listed on BioPortfolio]

Achieving Heisenberg-Scaling Precision with Projective Measurement on Single Photons.

It has been suggested that both quantum superpositions and nonlinear interactions are important resources for quantum metrology. However, to date the different roles that these two resources play in t...

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances.

Biomarker detection is one of the more important biomedical questions for high-throughput 'omics' researchers, and almost all existing biomarker detection algorithms generate one biomarker subset with...

Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas.

BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery.

Single-nucleotide variation and gene expression of disease samples represent important resources for biomarker discovery. Many databases have been built to host and make available such data to the com...

Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.

Biomarkers are a key component of precision medicine. However, full clinical integration of biomarkers has been met with challenges, partly attributed to analytical difficulties. It has been shown tha...

Clinical Trials [2858 Associated Clinical Trials listed on BioPortfolio]

Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation

CereDx has early proof of concept clinical data of a multi-omic peripheral blood biomarker profile that can be used to determine stroke from no stroke in the emergency setting. The objecti...

Instrument Precision Study for Validation of Philips Dx

The objective of this study is to evaluate precision of the Philips Dx system.

Dendritic Cell-precision T Cell for Neo-antigen in the Treatment of Advanced Biliary Tract Malignant Tumor

Objectives: The purpose of this study is to evaluate the safety and prognosis of dendritic cell-precision T cell for neo-antigen in the treatment of advanced biliary tract malignant ...

Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD): Improving Targeting Precision

When comparing targeting precision between DBS in parkinsonian patients and OCD patients, an unexpected deviation from the planned targets was discovered in OCD patients (Nuttin et al., 20...

Surefire Precision Infusion System Registry

This project involves the collection and analysis of retrospective and prospective data on patients diagnosed with hepatocellular carcinoma (HCC) in which the Surefire Precision Infusion S...

Companies [1396 Associated Companies listed on BioPortfolio]

Precision Biomarker Resources, Inc.

Precision accelerates its clients’ research and drug development by working closely with them on targeted biomarker discovery services, including microarray processing, experimental design consultat...

Powering Precision Health

The official sponsors partnering with the summit to bring precision health technologies to the forefront of medicine include premier sponsor Quanterix, the leading company digitiz...

ABL, Inc. and Aushon BioSystems

Aushon BioSystems, Inc. is leading the way in protein biomarker discovery, development and analysis. Through the unique combination of proprietary microarray printing, extensive b...


BiomarkerBase™ ( includes every molecular biomarker on a drug label, every biomarker in a PMA-approved diagnostic, prognostic, or companion diagn...

Precision Spine, Inc.

Precision Spine, Inc. is a privately held company with its executive headquarters in Parsippany, NJ. Precision Spine is the parent company of its wholly owned subsidiaries, Spinal...

More Information about "Precision Biomarker Resources, Inc." on BioPortfolio

We have published hundreds of Precision Biomarker Resources, Inc. news stories on BioPortfolio along with dozens of Precision Biomarker Resources, Inc. Clinical Trials and PubMed Articles about Precision Biomarker Resources, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Precision Biomarker Resources, Inc. Companies in our database. You can also find out about relevant Precision Biomarker Resources, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record